1.Partially Cystic Thyroid Nodules: Ultrasound Findings of Malignancy.
Jang Mi PARK ; Yoonjung CHOI ; Hyon Joo KWAG
Korean Journal of Radiology 2012;13(5):530-535
OBJECTIVE: To seek for the ultrasound (US) findings of partially cystic thyroid nodules that are associated with malignancy. MATERIALS AND METHODS: We reviewed the US characteristics of 22 surgically confirmed partially cystic papillary carcinomas, and compared them with those of 80 benign partially cystic nodules. The review cases were selected in a random order from a total of 1029 partially cystic nodules that were diagnosed with an US-guided fine needle aspiration biopsy over a period of 8 years (June 2003 to October 2010) at our institution. RESULTS: In partially cystic thyroid nodules, a taller-than-wide shape (100%, p < 0.001) and spiculated or microlobulated margin (58.3%, p = 0.003) were significantly associated with malignancy. In terms of internal solid portion of the nodule, eccentric configuration (68.0%, p < 0.001), non-smooth margin (81.3%, p < 0.001), hypoechogenecity (30.0%, p < 0.042), and microcalcification (89.5%, p < 0.001) were more frequently demonstrated in malignant nodules than benign ones. CONCLUSION: In partially cystic thyroid nodules, understanding the characteristics of US findings is important to make a precise diagnosis of malignant nodules.
Adolescent
;
Adult
;
Aged
;
Biopsy, Fine-Needle
;
Carcinoma, Papillary/pathology/surgery/*ultrasonography
;
Case-Control Studies
;
Chi-Square Distribution
;
Cysts/pathology/surgery/*ultrasonography
;
Female
;
Humans
;
Male
;
Middle Aged
;
Statistics, Nonparametric
;
Thyroid Neoplasms/pathology/surgery/*ultrasonography
;
Thyroid Nodule/pathology/surgery/*ultrasonography
2.Cost-Effectiveness Analysis of Germline and Somatic BRCA Testing in Patients With Advanced Ovarian Cancer
Jaehyeok JANG ; Yoonjung KIM ; Jae-Hoon KIM ; Sun-Mi CHO ; Kyung-A LEE
Annals of Laboratory Medicine 2023;43(1):73-81
Background:
BRCA testing is necessary for establishing a management strategy for ovarian cancer. Several BRCA testing strategies, including germline and somatic testing, are implemented in clinical practice in Korea. We aimed to comparatively evaluate their cost-effectiveness from patients’ perspective.
Methods:
We developed a decision model comprising five BRCA testing strategies implemented in Korea: (1) germline testing first, followed by somatic tumor testing for patients without a germline variant; (2) somatic testing first, followed by germline testing for patients with a variant detected by somatic testing; (3) both germline and somatic testing; (4) germline testing alone; and (5) somatic testing alone, with no testing as the comparator. One-way sensitivity analysis was conducted to test the uncertainty of key parameters.
Results:
Assuming a willingness-to-pay of $20,000 per progression-free life-year gain (PF-LYG), all five strategies were considered cost-effective. Strategy 4 was the most cost-effective option, with an incremental cost-effectiveness ratio (ICER) of $2,547.7 per PF-LYG, followed by strategy 1, with an ICER of $3,978.4 per PF-LYG. Even when the parameter values were varied within the possible range, the ICERs of all strategies did not exceed the willingness-to-pay threshold.
Conclusions
Considering the importance of knowing a patient’s BRCA gene status, germline testing first, followed by somatic testing, may be a reasonable option.
3.Effectiveness and Tolerability of Dual Therapy with Dolutegravir Plus Darunavir/ cobicistat in Treatment-Experienced Patients with HIV: A 144-Week Follow-Up
Shin-Woo KIM ; Hyun Wook JANG ; Hyun-Ha CHANG ; Yoonjung KIM ; Sohyun BAE
Infection and Chemotherapy 2024;56(2):247-255
Background:
A dual regimen with dolutegravir plus cobicistat-boosted darunavir (DTG+DRV/c) is a promising alternative for patients with human immunodeficiency virus (HIV) with resistance or intolerance to nucleoside reverse transcriptase inhibitors, especially those with a history of treatment failure.
Materials and Methods:
We included all treatment-experienced patients with HIV who switched to the DTG+DRV/c regimen at a tertiary university hospital. We assessed the regimen's effectiveness, safety, and tolerability through serial laboratory data and clinical findings. The primary endpoint was the proportion of patients with plasma HIV-RNA levels <50 copies/mL at week 144 post-switch. The secondary endpoints were safety and tolerability assessments.
Results:
Our retrospective analysis involved 40 patients. The leading reasons for switching to DTG+DRV/c were treatment failure in 17 patients (42.5%), simplification after multiple previous regimens in 15 (37.5%), and adverse drug reactions in 8 (20.0%). Among the 17 patients in the treatment failure group, we observed enhanced viral suppression and improved CD4+ T-cell counts after initiating the dual regimen. In the non-treatment failure group (23 patients), viral suppression and CD4+ T-cell levels were consistently maintained. No significant alterations in renal function, liver function, glucose levels, or lipid profiles were observed post-switch. High tolerability was observed, with 34/40 patients (85.0%) responding well to the regimen. However, six patients discontinued treatment before reaching the 144-week mark.
Conclusion
Our findings confirm that DTG+DRV/c is an effective and well-tolerated switch therapy regimen for treatment-experienced patients with HIV, with sustained benefits observed for up to 144 weeks of follow-up. This regimen showed adaptability across different patient groups and demonstrated virological and immunological improvements, particularly in patients with a history of treatment failure.
4.Association between I/D, G14480C, A22982G Polymorphisms of Angiotesin I-Converting Enzyme Gene and Essential Hypertension in the Korean Population.
Jongmin KIM ; Dong Jik SHIN ; Yoonjung BAE ; Sook KIM ; Jong Eun LEE ; Chanmi PARK ; Hyun Young PARK ; Sungjoo KIM YOON ; Yangsoo JANG
Korean Circulation Journal 2004;34(12):1137-1147
BACKGROUND AND OBJECTIVES: The renin-angiotensin system (RAS) genes have been studied extensively as etiologic essential hypertension (EH) candidate genes in human populations worldwide. The angiotensin I-converting enzyme (ACE) plays an important role in the RAS for the regulation of blood pressure. Recent reports on the association of ACE gene polymorphisms with EH and the related cardiovascular diseases have been controversial. Therefore, this study investigated the association of three polymorphisms (I/D, G14480C and A22982G) in the ACE gene with EH in Koreans. SUBJECTS AND METHODS: This study recruited a sample population of 887 Koreans (comprising of 461 controls and 426 EH cases) from Cardiovascular Genome Center in Korea. The ACE gene polymorphisms were determined by a polymerase chain reaction and a SNP-IT assay. RESULTS: The genotype and the allele frequencies of all three polymorphisms in the hypertensives and the normotensives not significantly different (p>0.05). In the female control group, there was a significant difference in SBP among the genotype with the I/D polymorphism (p<0.05). There was also an association between the ACE polymorphisms and the hypertensive male group with the total cholesterol level. Haplotype analysis showed that none of the haplotypes were significantly associated with hypertension. CONCLUSION: ACE polymorphisms do not appear to have any apparent association with essential hypertension in Koreans, who have a more homogeneous genetic structure than other ethnic groups.
Asian Continental Ancestry Group
;
Blood Pressure
;
Cardiovascular Diseases
;
Cholesterol
;
Ethnic Groups
;
Female
;
Gene Frequency
;
Genetic Structures
;
Genome
;
Genotype
;
Haplotypes
;
Humans
;
Hypertension*
;
Korea
;
Male
;
Peptidyl-Dipeptidase A
;
Polymerase Chain Reaction
;
Renin-Angiotensin System
5.Hypocitraturia-related Ureteral Steinstrasse in a Renal Transplant Recipient.
Jeong Gu NA ; Sung Min KONG ; Dong Gyu LEE ; Seong Min KIM ; Yoonjung JANG ; Sung Rok KIM ; Yu Ji LEE
The Ewha Medical Journal 2015;38(3):117-120
Urolithiasis is an uncommon complication in renal transplantation. We report a case of hypocitraturia-related ureteral steinstrasse which was spontaneously formed in a renal transplant recipient. The patient who underwent renal transplantation was admitted with acute pyelonephritis. Hydronephrosis in the transplanted kidney and multiple stones (steinstrasse) in the distal ureter were incidentally found on computed tomography scanning. After a failed attempt of ureteroscopic removal of stones, the patient underwent open ureterolithotomy and ureteroureterostomy. On stone analysis, carbonate apatite was confirmed. Urinary citric acid levels were decreased to 127.6 mg/day. Potassium citrate was administered to prevent stone recurrence by increasing urinary citrate excretion. No recurrence of stones was shown six months later. Urolithiasis in renal transplant recipients requires a high index of suspicion. Hypocitraturia can increase the risk for urolithiasis. Rapid recognition by careful surveillance, prompt removal of stones, and precautionary efforts to prevent recurrence are needed.
Carbon
;
Citric Acid
;
Humans
;
Hydronephrosis
;
Kidney
;
Kidney Transplantation
;
Potassium Citrate
;
Pyelonephritis
;
Recurrence
;
Transplantation*
;
Ureter*
;
Urolithiasis
6.Intravenous albumin for the prevention of contrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease undergoing contrast-enhanced CT.
Heejung CHOI ; Yoonjung KIM ; Soo Min KIM ; Junam SHIN ; Hye Ryoun JANG ; Jung Eun LEE ; Wooseong HUH ; Yoon Goo KIM ; Ha Young OH ; Dae Joong KIM
Kidney Research and Clinical Practice 2012;31(2):106-111
BACKGROUND: The purpose of this study was to evaluate the incidence of contrast-induced nephropathy (CIN), and the effect of intravenous albumin for prophylaxis of CIN in patients with liver cirrhosis (LC) and chronic kidney disease (CKD). METHODS: We conducted a retrospective study of 81 subjects with LC and CKD (estimated glomerular filtration rate (eGFR)<60mL/min/1.73m2) who underwent contrast-enhanced computed tomography (CT). Patients received either isotonic sodium bicarbonate solution (3mL/kg for 1h before CT and 1mL/kg/h for 6h after CT) or albumin (20% albumin, 25mL for 1h before CT and 75mL for 6h after CT). CIN was defined as an increase of > or =25% or > or =0.5mg/dL in serum creatinine level. RESULTS: Overall, CIN developed in three patients (3.7%). Of the 81 subjects, 43 received sodium bicarbonate solution and 38 received albumin. Both groups were comparable with regard to age, sex, diabetes mellitus, and baseline eGFR. The albumin group showed a significantly poorer liver function profile. CIN incidence did not differ significantly between the groups: it occurred in one (2.3%) of the 43 subjects receiving sodium bicarbonate and two (5.3%) of the 38 subjects receiving albumin (P=0.6). However, the albumin group showed a significantly smaller increase in body weight (P=0.03). CONCLUSION: The incidence of CIN in patients with LC and CKD undergoing contrast-enhanced CT after preventive measures was relatively low. The incidence of CIN was not significantly different between sodium bicarbonate and albumin groups.
Body Weight
;
Creatinine
;
Diabetes Mellitus
;
Glomerular Filtration Rate
;
Humans
;
Incidence
;
Liver
;
Liver Cirrhosis
;
Renal Insufficiency, Chronic
;
Retrospective Studies
;
Sodium Bicarbonate
7.The Knowledge, Attitudes, Performance, and Barriers of Nurses to Pain in Oncology Settings:A Multi-Center Study
Hyekyung KIM ; Soeun CHOI ; Sue KIM ; Jiyeon LEE ; Sun-Hee KIM ; Insook LEE ; Yoonjung SHIN ; Hye-Young JANG
Asian Oncology Nursing 2021;21(1):15-23
Purpose:
The purpose of this study was to examine knowledge, attitudes, performance, and barriers to pain management of nurses working in oncology settings.
Methods:
This cross-sectional study was conducted on 222 nurses in five tertiary hospitals in Korea.The period of data collection was 1 September to 30 November 2018. Participants were surveyed using the Nurse Knowledge and Attitudes Survey Regarding Pain (NKASRP), a pain management performance, and barriers questionnaire. The data were analyzed through independent t-test and One-way ANOVA, and the post-hoc test was conducted with the Scheffé test using the SPSS 23 program.
Results:
According to the study, oncology nurses’ knowledge and attitudes to pain received a score of 26.4±3.77 (out of 41 points) and the performance received a score of 3.24±0.35 (out of 4 points). Among the barriers to pain management, time constraints were the most frequent medical staff-related factor, and reluctance to take opioids was the most frequent patient-related factor. In terms of factors related to the health care system, strict regulation of opioids was the most significant. There was a significant positive correlation between knowledge and attitude of pain management and performance of pain management.
Conclusion
Based on the findings of this study, it is recommended that structured education programs to be developed and implemented to enhance knowledge, attitudes, and performance on pain.
8.The Knowledge, Attitudes, Performance, and Barriers of Nurses to Pain in Oncology Settings:A Multi-Center Study
Hyekyung KIM ; Soeun CHOI ; Sue KIM ; Jiyeon LEE ; Sun-Hee KIM ; Insook LEE ; Yoonjung SHIN ; Hye-Young JANG
Asian Oncology Nursing 2021;21(1):15-23
Purpose:
The purpose of this study was to examine knowledge, attitudes, performance, and barriers to pain management of nurses working in oncology settings.
Methods:
This cross-sectional study was conducted on 222 nurses in five tertiary hospitals in Korea.The period of data collection was 1 September to 30 November 2018. Participants were surveyed using the Nurse Knowledge and Attitudes Survey Regarding Pain (NKASRP), a pain management performance, and barriers questionnaire. The data were analyzed through independent t-test and One-way ANOVA, and the post-hoc test was conducted with the Scheffé test using the SPSS 23 program.
Results:
According to the study, oncology nurses’ knowledge and attitudes to pain received a score of 26.4±3.77 (out of 41 points) and the performance received a score of 3.24±0.35 (out of 4 points). Among the barriers to pain management, time constraints were the most frequent medical staff-related factor, and reluctance to take opioids was the most frequent patient-related factor. In terms of factors related to the health care system, strict regulation of opioids was the most significant. There was a significant positive correlation between knowledge and attitude of pain management and performance of pain management.
Conclusion
Based on the findings of this study, it is recommended that structured education programs to be developed and implemented to enhance knowledge, attitudes, and performance on pain.
9.Slowly Progressing Thrombotic Microangiopathy during Two Years of Treatment with Sunitinib.
Min Young KIM ; Heejung CHOI ; Yoonjung KIM ; Na Ree KANG ; Hye Ryoun JANG ; Ghee Young KWON ; Wooseong HUH ; Young Suk PARK ; Yoon Goo KIM ; Dae Joong KIM ; Ha Young OH ; Jung Eun LEE
Korean Journal of Nephrology 2011;30(5):533-536
A 75-year-old man with mild renal impairment was started on sunitinib for a metastatic gastrointestinal stromal tumor. After 7 months of this therapy, proteinuria became aggravated. Serum creatinine concentration was increased from 1.34 to 2.57 mg/dL 24 months after sunitinib administration. Hematologic features of thrombotic microangiopathy (TMA) were absent. Renal histology revealed endothelial swelling and plasmatic insudation of the glomeruli. Proteinuria and renal function improved after discontinuation of sunitinib. Our experience suggests that TMA associated with sunitinib can be diverse in onset and severity, and that the hematologic features of TMA may be absent.
Aged
;
Creatinine
;
Gastrointestinal Stromal Tumors
;
Humans
;
Indoles
;
Proteinuria
;
Pyrroles
;
Thrombotic Microangiopathies
;
Vascular Endothelial Growth Factor A
10.Evaluation of the DG Gel System using the Microtube Column Agglutination Technique for Antibody Screening and Identification.
Jee Yong KIM ; Ji Hoon HUH ; Sun Hyung KIM ; Myung Hyun NAM ; Kyoung Ho ROH ; Jang Su KIM ; Sook Young BAE ; Jin Hyuk YANG ; Soo Young YOON ; Chae Seung LIM ; Chang Kyu LEE ; Yoonjung CHO ; Young Kee KIM ; Kap No LEE
Korean Journal of Blood Transfusion 2007;18(1):32-38
BACKGROUND: For the antibody screening test, the classical LISS tube indirect antiglobulin test has been replaced by the microtube column agglutination system in Korea. This system was first created in 1990 by Lapierre and it is distributed through DiaMed (DiaMed Ag, Cresssier, Morat, Switzerland) around the world. Similar systems, such as Ortho BioVue, have been developed and competed after that. We evaluated a newly developed microtube column agglutination system, DG Gel (Diagnostic Grifols, Barcelona, Spain), and we compare it with the other established systems. METHODS: In a comparative study, a total of 126 samples, including 76 antibody screening positive samples and 50 negative samples, were tested in parallel by the LISS/Coombs card (DiaMed Ag, Cresssier, Morat, Switzerland) and the DG Gel microtube column agglutination system. The positive samples that were proved by the LISS/Coombs card and the DG Gel system were identified by the ID-Dia panel (DiaMed Ag, Cresssier, Morat, Switzerland) and Identisera Diana (Diagnostic Grifols, Barcelona, Spain). Discrepant samples were rechecked with I, II and III cells that were supplied by the panel of the Korea Red Cross Blood Center. RESULTS: Among the 126 samples, the DG Gel antibody screening system showed 98.7% (75/76) sensitivity and 100% (50/50) specificity. We obtained concordant results in 75 samples (98.7%) and discrepant results in one sample (1.32%) between the DG Gel and DiaMed-ID for antibody identification. CONCLUSION: Both the microtube column agglutination systems work well and showed high estimated sensitivity and specificity with high concordance. Therefore, the DG gel microtube column agglutination system can be used with good results.
Agglutination*
;
Coombs Test
;
Korea
;
Mass Screening*
;
Red Cross
;
Sensitivity and Specificity